Abbvie Acquires Apogee
Abbvie is acquiring Apogee Therapeutics in a deal valuing Apogee at $10.9 billion
Deal Values Apogee At $10.9 Bln Equity Value
Abbvie is acquiring Apogee Therapeutics in a deal valuing Apogee at $10.9 billion
Deal Values Apogee At $10.9 Bln Equity Value